Abstract
Results: The MTHFR 677C > T and 1298A > C polymorphisms were not associated with survival or relapse-free survival (P > 0.2). The 677 CC genotype was associated to toxicity (odds ratio = 1.83, P = 0.01).
Conclusions: The MTHFR 677C > T and 1298A > C polymorphisms probably do not predict efficacy of adjuvant 5-FU treatment in colorectal cancer after complete resection; however, the 677C > T polymorphism may be associated with lower toxicity in 5-FU treatment. Implementation of SNP analysis for these polymorphisms for individualized treatment is premature.
Original language | English |
---|---|
Journal | Annals of Oncology |
Volume | 20 |
Issue number | 10 |
Pages (from-to) | 1660-1666 |
ISSN | 0923-7534 |
DOIs | |
Publication status | Published - 2009 |
Keywords
- colorectal cancer
- 5-fluorouracil
- methylenetetrahydrofolate reductase
- pharmacogenetics
- single-nucleotide polymorphisms